 |
|
|
October 1th, 2009 Study results of prostate cancer patients treated with CyberKnife RadiosurgeryCyberKnife prostate radiosurgery is a non-invasive, outpatient treatment that is typically completed in a single week, making it more convenient for patients than six to eight weeks of conventional radiation therapy or an invasive prostatectomy that requires patients to have general anesthesia and an overnight hospital stay. The CyberKnife's ability to track and correct for movement of the prostate allows to focus the radiation dose on the prostate and spare surrounding tissues, like the nerves, resulting in erectile function preservation in a majority of patients. One of study participants, retired Orthopedic Surgeon Scott Silver, M.D, said that he was looking for a treatment that offered the best chance for a complete cure, but at the same time, it was extremely important to him to avoid complications such as impotence, incontinence and bowel problems, that commonly result from prostate cancer treatment. Finally, he was pleased to report that after three and a half years post-treatment, he remains cancer-free with his quality of life 100 percent intact. According to David M. Spellberg, M.D, one of study leaders, "These data are encouraging for the millions of men diagnosed with prostate cancer looking for a non-invasive therapy that will preserve their quality of life." This study of 112 patients, achieved 97 percent sustained PSA response at two years, with urinary and rectal side effect profiles comparable to conventional radiation therapy. NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|